Log In
Print
BCIQ
Print
Print this Print this
 

SX-PCK9

  Manage Alerts
Collapse Summary General Information
Company Serometrix LLC
DescriptionProprotein convertase subtilisin/kexin type 9 (PCSK9) antagonist
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today